Back to HomeBeta

ICD-10 Coding for Euglycemic Diabetic Ketoacidosis(E10.10, E11.10)

Complete ICD-10-CM coding and documentation guide for Euglycemic Diabetic Ketoacidosis. Includes clinical validation requirements, documentation requirements, and coding pitfalls.

Also known as:

EDKAEuglycemic DKA

Quick Navigation

Related ICD-10 Code Ranges

Complete code families applicable to Euglycemic Diabetic Ketoacidosis

E10.1-E11.1Primary Range

Diabetic ketoacidosis codes for type 1 and type 2 diabetes

These codes are used to classify diabetic ketoacidosis, including euglycemic presentations, based on diabetes type.

T45.1X5A

Adverse effects of SGLT2 inhibitors

This code is used when EDKA is induced by SGLT2 inhibitors.

O24.4

Gestational diabetes codes

Used when EDKA occurs in the context of gestational diabetes.

Code Comparison: When to Use Each Code

Compare key differences between these codes to ensure accurate selection

CodeDescriptionWhen to UseKey Documentation
E10.10Type 1 diabetes mellitus with ketoacidosis without comaUse when EDKA is diagnosed in a patient with type 1 diabetes.
  • pH <7.3
  • Bicarbonate <18 mmol/L
  • Serum β-hydroxybutyrate >3.0 mmol/L
  • + 1 more
E11.10Type 2 diabetes mellitus with ketoacidosis without comaUse when EDKA is diagnosed in a patient with type 2 diabetes.
  • pH <7.3
  • Bicarbonate <18 mmol/L
  • Serum β-hydroxybutyrate >3.0 mmol/L
  • + 1 more

Clinical Decision Support

Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.

Key Information: ICD-10 code for euglycemic diabetic ketoacidosis

Essential facts and insights about Euglycemic Diabetic Ketoacidosis

Euglycemic diabetic ketoacidosis is coded as E10.10 or E11.10, depending on diabetes type, with additional codes for drug-induced cases.

Primary ICD-10-CM Codes for euglycemic diabetic ketoacidosis

E10.10
Type 1 diabetes mellitus with ketoacidosis without coma
Billable Code

Decision Criteria

clinical Criteria

  • Presence of acidosis with normal glucose levels in type 1 diabetes

Applicable To

  • Type 1 diabetes with euglycemic DKA

Excludes

  • Starvation ketosis (R78.2)

Clinical Validation Requirements

  • pH <7.3
  • Bicarbonate <18 mmol/L
  • Serum β-hydroxybutyrate >3.0 mmol/L
  • Blood glucose <250 mg/dL

Code-Specific Risks

  • Misclassification as hyperglycemic DKA

Coding Notes

  • Ensure documentation specifies type 1 diabetes and presence of acidosis.
View Full Code Details

Ancillary Codes

Additional codes that should be used in conjunction with the main diagnosis codes when applicable.

Adverse effect of SGLT2 inhibitors

T45.1X5A
Use if EDKA is induced by SGLT2 inhibitors.

Differential Codes

Alternative codes to consider when ruling out similar conditions to the primary diagnosis.

Starvation ketosis

R78.2
Use only if documentation explicitly states non-diabetic starvation ketosis.

Documentation & Coding Risks

Avoid these common documentation and coding issues when documenting Euglycemic Diabetic Ketoacidosis to ensure proper reimbursement, maintain compliance, and reduce audit risk. These guidelines are particularly important when using ICD-10 code E10.10.

Impact

Clinical: Incomplete clinical picture of drug effects., Regulatory: Non-compliance with coding standards., Financial: Potential loss of reimbursement for drug-related complications.

Mitigation Strategy

Review medication lists for SGLT2 inhibitors., Ensure adverse effects are documented.

Impact

Reimbursement: Incorrect DRG assignment may affect reimbursement., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate clinical data representation.

Mitigation Strategy

Ensure documentation specifies normal glucose levels and presence of acidosis.

Impact

Reimbursement: Potential underpayment due to incomplete coding., Compliance: Failure to capture drug-induced conditions., Data Quality: Incomplete data on drug-related adverse effects.

Mitigation Strategy

Include T45.1X5A when EDKA is induced by SGLT2 inhibitors.

Impact

Failure to document all required elements for EDKA coding.

Mitigation Strategy

Implement EHR prompts for required documentation elements.

Documentation errors, coding pitfalls, and audit risks are interconnected aspects of medical coding and billing. Addressing all three areas helps ensure accurate coding, optimal reimbursement, and regulatory compliance.

Frequently Asked Questions

Common questions about ICD-10 coding for Euglycemic Diabetic Ketoacidosis, with expert answers to help guide accurate code selection and documentation.

Documentation Templates for Euglycemic Diabetic Ketoacidosis

Use these documentation templates to ensure complete and accurate documentation for Euglycemic Diabetic Ketoacidosis. These templates include all required elements for proper coding and billing.

EDKA due to SGLT2 inhibitors

Specialty: Endocrinology

Required Elements

  • Patient presentation
  • Lab results
  • Medication history
  • Treatment plan

Example Documentation

Patient presents with nausea and abdominal pain. Labs: pH 7.25, bicarbonate 15 mmol/L, serum ketones 4.5 mmol/L. Diagnosed with euglycemic DKA due to empagliflozin.

Examples: Poor vs. Good Documentation

Poor Documentation Example
DKA with normal glucose.
Good Documentation Example
Euglycemic DKA (pH 7.25, β-OHB 4.2 mmol/L) secondary to empagliflozin in type 2 DM.
Explanation
The good example specifies the type of diabetes, the drug involved, and provides lab values.

Need help with ICD-10 coding for Euglycemic Diabetic Ketoacidosis? Ask your questions below.

Ask about any ICD-10 CM code, or paste a medical note

We build tools for
clinician happiness.

Learn More at Freed.ai
Back to HomeBeta

Built by Freed

Try Freed for free for 7 days.

Learn more

Helpful Links

How ICD 10 AI Lookup WorksContact UsPrivacy Policy